# SYMFI LO
> **NDA208255** · New Drug Application · Sponsor: MYLAN · Approved 2018-02-05
## Drug
- **FDA Application Number:** NDA208255
- **Application type:** New Drug Application
- **Brand name:** SYMFI LO
- **Generic name:** Efavirenz
- **Active ingredients:** EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
- **First approval:** 2018-02-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208255)
---
*AI Analytics · CC0 1.0*